Product
T Cell-Depleted Donor Lymphocyte Infusion
1 clinical trial
13 indications
Indication
Acute Myeloid LeukemiaIndication
Aplastic AnemiaIndication
Chronic Myelomonocytic LeukemiaIndication
Hodgkin lymphomaIndication
Indolent Non-Hodgkin LymphomaIndication
CancerIndication
Myelodysplastic SyndromeIndication
Myeloproliferative NeoplasmIndication
Multiple MyelomaIndication
Refractory AnemiaIndication
Refractory Anemia With Ring SideroblastsClinical trial
A Two Step Approach to Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic MalignanciesStatus: Active (not recruiting), Estimated PCD: 2024-02-13